Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

92.73

-5.34 (-5.45%)

At close: Feb 27, 2026, 4:00 PM EST

92.66

-0.07 (-0.08%)

After-hours: Feb 27, 2026, 7:32 PM EST

Rhythm Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-260.6	-184.68	-181.12	-69.61
Depreciation & Amortization	1.56	1.76	1.67	1.16
Loss (Gain) From Sale of Investments	-8.17	-9.84	-1.27	-
Stock-Based Compensation	39.68	32.55	19.83	20.8
Other Operating Activities	103.07	19.24	4.87	-100.25
Change in Accounts Receivable	-3.65	-8.64	-5.2	-1.25
Change in Inventory	-10.12	-5.71	-2.81	-0.01
Change in Accounts Payable	21.92	14.77	1.54	18.31
Change in Unearned Revenue	-	-0.15	-6.61	-
Change in Other Net Operating Assets	2.42	4.53	-4.34	-15.15
Operating Cash Flow	-113.88	-136.16	-173.43	-146
Capital Expenditures	-	-0.05	-0.28	-0.43
Sale (Purchase) of Intangibles	-40.5	-5.67	-	7
Investment in Securities	-7.67	0.05	32.31	-163.73
Other Investing Activities	-	-	-4	95
Investing Cash Flow	-48.17	-5.67	28.03	-62.16
Issuance of Common Stock	56.39	57.4	141.49	166.48
Other Financing Activities	-4	16.97	72.34	-
Financing Cash Flow	191.24	74.37	213.83	166.48
Foreign Exchange Rate Adjustments	0	-0.14	-	-
Net Cash Flow	29.19	-67.6	68.43	-41.68
Free Cash Flow	-113.88	-136.2	-173.71	-146.44
Free Cash Flow Margin	-87.51%	-175.91%	-734.87%	-4642.90%
Free Cash Flow Per Share	-1.87	-2.36	-3.33	-2.95
Levered Free Cash Flow	-139.74	-91.47	-105.11	-57.05
Unlevered Free Cash Flow	-126.86	-82.79	-101.86	-57.05
Change in Working Capital	10.58	4.81	-17.41	1.9

Updated Feb 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q